About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Examination of Efficacy and Safety of Baricitinib in RA Patients

NCT03755466·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Shinshu University

Age

20–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

RA patients

You may not be if

Not RA patients
RA patients who are allergic to the drugs, refused to do this research, or who are pregnant

The record

StatusUnknown

PhasePhase 2

Taking part90

StartedNov 2018

UpdatedSep 21, 2021

Conditions

Rheumatoid Arthritis

Where1

Yukio Nakamura
Matsumoto, Nagano, Japan

Clareo Health | Examination of Efficacy and Safety of Baricitinib in RA Patients